正在為您準備內容...
正在為您準備內容...
成份 · Ingredient
卡培他濱
卡培他濱是一種口服抗癌藥物，屬於氟嘧啶類抗代謝藥物的前驅藥。它在體內會轉化為5-氟尿嘧啶（5-FU），主要用於治療多種癌症，包括結直腸癌和乳癌。此藥物能干擾癌細胞的DNA合成，從而抑制腫瘤生長。
Capecitabine is a carbamate ester that is cytidine in which the hydrogen at position 5 is replaced by fluorine and in which the amino group attached to position 4 is converted into its N-(penyloxy)carbonyl derivative. Capecitabine is a antineoplastic agent used in the treatment of cancers. It has a role as an antimetabolite, an antineoplastic agent and a prodrug. It is a carbamate ester, a member of cytidines and an organofluorine compound.
| 藥品名稱 | 成份 | 號碼 |
|---|---|---|
| ACCORD CAPECITABINE TABLETS 150MG | HK-64024 | |
| ACCORD CAPECITABINE TABLETS 500MG | HK-64025 | |
| CAPECITABIN CELL PHARM TABLETS 150MG | HK-65032 | |
| CAPECITABIN CELL PHARM TABLETS 500MG | HK-65033 | |
| CAPECITABINE NORMON TABLETS 150MG | HK-66207 | |
| CAPECITABINE NORMON TABLETS 500MG | HK-66208 | |
| CAPECITABINE SANDOZ TABLET 150MG | HK-62913 | |
| CAPECITABINE SANDOZ TABLET 500MG | HK-62914 | |
| CAPECITABINE TABLETS 0.5G | HK-64481 | |
| CAPECITABINE TABLETS 150MG | HK-68948 | |
| CAPECITABINE TABLETS 150MG | HK-62794 | |
| CAPECITABINE TABLETS 500MG | HK-68949 | |
| CAPECITABINE TABLETS 500MG | HK-62795 | |
| CAPECITABINE TABLETS USP 500MG | HK-65481 | |
| CAPECITABINE-DRLA TABLETS 150MG | HK-64724 | |
| CAPECITABINE-DRLA TABLETS 500MG | HK-64725 | |
| CAPECITABINE-TEVA FILM-COATED TABLETS 150MG | HK-63403 | |
| CAPECITABINE-TEVA FILM-COATED TABLETS 500MG | HK-63404 | |
| FACIVIX TABLETS 150MG | HK-68773 | |
| FACIVIX TABLETS 500MG | HK-68774 |
藥品資料來源：香港衞生署藥物辦公室 · 化學資料來源：PubChem (NIH) · 資料僅供參考，不構成醫療建議